financetom
Market
financetom
/
Market
/
TVS Motors has achieved this landmark for the first time in 25 years
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
TVS Motors has achieved this landmark for the first time in 25 years
Oct 14, 2022 5:00 AM

Share Market Live

NSE

Chennai-based TVS Motor Co. has become the sixth-most valued listed automobile company in the country, pipping Hero Moto for the position on Friday. Shares gained as much as 2.6 percent on Friday before cooling off. In the process, it achieved market capitalisation of Rs 51,750 crore compared to Hero's Rs 51,300 crore in intraday trading.

Since 1997, this is the first time that TVS Motor has a market capitalisation greater than Hero Moto.

What's Working For TVS?

The two-wheeler maker is narrowing the profitability gap between its peers. The company's average EBITDA per vehicle has nearly tripled over the last decade from Rs 2,300 in financial year 2010 to Rs 6,400 in the June quarter of the current financial year.

This has meant that the company's EBITDA per vehicle is only 35 percent below the peer average. The share of TVS Motors' EBITDA among its peers has increased from 6 percent in financial year 2017 to 13 percent in the previous financial year.

TVS is also narrowing the margin gap with Hero over the last five quarters. For the September quarter, TVS' margin is likely to improve 50 basis points from last quarter and 80 basis points year-on-year.

Also Read: TVS Motor gets shareholders' nod for sale of entire stake in Sundaram Holding

For the September quarter, the company's overall sales volume increased 12 percent year-on-year, while three-wheeler sales increased 7 percent from last year.

Shares of TVS Motor are currently off the day's high but have gained over 70 percent this year, ranking among the top performing stocks on the Nifty Auto index.

First Published:Oct 14, 2022 2:00 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Tech
Sector Update: Tech
May 31, 2024
08:55 AM EDT, 05/31/2024 (MT Newswires) -- Technology stocks were mixed pre-bell Friday as the Technology Select Sector SPDR Fund (XLK) was up 0.5% and the SPDR S&P Semiconductor ETF (XSD) was 0.1% lower recently. Dell Technologies ( DELL ) shares declined by about 16% after the company reported a steeper-than-anticipated decline in fiscal Q1 earnings. ...
TREASURIES-US yields drift lower after inflation data
TREASURIES-US yields drift lower after inflation data
May 31, 2024
NEW YORK, May 31 (Reuters) - U.S. Treasury yields fell on Friday after data showed U.S. inflation for April came in line with expectations, suggesting that the Federal Reserve could keep rates unchanged for some time. The personal consumption expenditures (PCE) price index rose 0.3% last month, data showed, matching the unrevised gain in March. The benchmark 10-year yield slid...
Aptose Biosciences Down 14% In US Premarket As Plans to Raise Near $4.4 Million Via Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Aptose Biosciences Down 14% In US Premarket As Plans to Raise Near $4.4 Million Via Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
May 31, 2024
08:54 AM EDT, 05/31/2024 (MT Newswires) -- Aptose Biosciences Inc. ( APTO ) , a clinical-stage precision oncology company developing highly differentiated oral targeted agents to treat hematologic malignancies, said Friday that it plans to raise about US$4.4 million via A registered direct offering priced at-the-market under Nasdaq rules. Under the offering, the company will issue about 3.9 million of...
Sector Update: Health Care
Sector Update: Health Care
May 31, 2024
08:58 AM EDT, 05/31/2024 (MT Newswires) -- Health care stocks were flat to higher pre-bell Friday, with the iShares Biotechnology ETF (IBB) was inactive and the Health Care Select Sector SPDR Fund (XLV) up 0.4% recently. Summit Therapeutics ( SMMT ) fell more than 25%, cutting into its more than 137% surge Thursday after it said ivonescimab met the primary...
Copyright 2023-2026 - www.financetom.com All Rights Reserved